Chromadex Corp (NASDAQ:CDXC)
| 1.37 Delayed Data As of Sep 22 |  -0.02 / -1.44%Today’s Change | 1.15 Today|||52-Week Range 2.24 | -18.45% Year-to-Date |
Latest CDXC News | Press Releases
No recent news for Chromadex Corp.
Today’s Trading
| Previous close | 1.39 |
| Today’s open | 1.39 |
| Day’s range | 1.37 - 1.40 |
| Volume | 129 |
| Average volume (3 months) | 84,143 |
| Market cap | $111.8M |
Data as of 3:58pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +41.26% |
| Earnings growth (this year) | +46.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +6.82% |
| P/E ratio | NM |
| Price/Sales | 1.63 |
| Price/Book | 3.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATOSAtossa Therapeutics ... | +0.04 | +4.81% |
| CDTXCidara Therapeutics ... | -0.02 | -2.00% |
| OGIOrganiGram Holdings ... | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $72.1M |
| Annual profit (last year) | -$16.5M |
| Net profit margin | -22.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
